Abstract:Key PointsToll-like receptors (TLRs) and NOD-like receptors (NLRs) sense pathogen-associated molecules and trigger effector pathways to facilitate the destruction and removal of the pathogen. Post-translational modifications, such as ubiquitylation, have important roles in regulating the activities and the levels of signalling molecules in these pathways.The Pellino family (Pellino 1, Pellino 2 and Pellino 3) were initially identified as interleukin-1 receptor-associated kinase (IRAK)-interacting proteins with E3 ubiquitin ligase activity. They are activated by kinases such as IRAKs and TANK-binding kinase 1 (TBK1) and can promote ubiquitylation of their upstream kinases.Pellino 1 regulates TIR domain-containing adaptor protein inducing IFNβ (TRIF)-dependent signalling in the TLR3 and TLR4 pathways by promoting the ubiquitylation of the kinase receptor-interacting protein 1 (RIP1) and the downstream activation of nuclear factor-κB (NF-κB), and by mediating the TRIF-dependent induction of type I interferons (IFNs). In addition, in microglial cells, Pellino 1 can mediate the myeloid differentiation primary-response protein 88 (MYD88)-dependent activation of mitogen-activated protein kinase (MAPK) pathways to trigger neuroinflammation.Pellino 1 also functions as a negative regulator of T cell activation to ensure self tolerance is maintained and to avoid the development of autoimmunity.Pellino 3 negatively regulates the TLR3-induced expression of type I IFNs by ubiquitylating TNF receptor-associated factor 6 (TRAF6) to inhibit the downstream activation of IFN-regulatory factor 7 (IRF7). In addition, Pellino 3 mediates nucleotide-binding oligomerization domain-containing protein 2 (NOD2) signalling and regulates intestinal inflammation by functioning as the E3 ubiquitin ligase for the RIP2 kinase.Pellino 3 is cytoprotective in response to tumour necrosis factor (TNF) challenge, as it targets RIP1 and impairs the formation of the death-inducing signalling complex (DISC).Further investigation of the role of Pellino proteins in immunity will provide a molecular and a functional understanding of their contribution to physiological and pathological conditions.

The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome

The roles of Pellino E3 ubiquitin ligases in immunity

Pellino 2 Is critical for Toll-like Receptor/Interleukin-1 Receptor (TLR/IL-1R)-mediated Post-transcriptional Control

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity

Pellino 3b Negatively Regulates Interleukin-1-induced TAK1-dependent NFκB Activation

NLRP3 Phosphorylation is an Essential Priming Event for Inflammasome Activation.

Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation

NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation

An update on the regulatory mechanisms of NLRP3 inflammasome activation

Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activation

IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network

The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Pellino 1 is Required for Interleukin-1 (Il-1)-mediated Signaling Through Its Interaction with the IL-1 Receptor-associated Kinase 4 (Irak4)-Irak-tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Complex

Protein kinase D at the Golgi controls NLRP3 inflammasome activation

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain

E3 Ubiquitin Ligase Nedd4 is a Key Negative Regulator for Non-Canonical Inflammasome Activation

Regulation of NLRP3 Inflammasome by Phosphorylation

Structural basis for the oligomerization-facilitated NLRP3 activation

Priming of NLRP3 Inflammasome Activation by Msn Kinase MINK1 in Macrophages